By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


PharmaMar S.A. 

Pol Ind. la Mina Avenida de los Reyes, 1

Colmenar Viejo  Madrid  28770  Spain
Phone: 34-91-8466000 Fax: 34-91-8466001


Company News
Myriad Genetics, Inc. (MYGN) Partners With PharmaMar S.A. for New HRD Test 3/29/2013 8:23:55 AM
Spanish Biotech PharmaMar S.A. Selects Medidata Solutions, Inc. Clinical Cloud to Accelerate Trials for Marine-Based Oncology Drugs 3/18/2013 10:07:36 AM
PharmaMar S.A. Commences Clinical Trial in U.S. with New Antitumor Product, PM060184 2/8/2011 8:14:33 AM
PharmaMar S.A. Initiates a Phase III Registration Trial with Aplidin(R) in Multiple Myeloma Patients 6/9/2010 10:06:36 AM
PharmaMar S.A. Presents New Clinical Trials With Three Marine-Based Drugs at the American Association for Cancer Research Convention 4/22/2010 10:58:40 AM
Zeltia Group (18494051.MA)'s PharmaMar S.A. in Deal With US Medimetriks Pharmaceuticals, Inc. 6/10/2009 7:20:23 AM
Innovex (INVX) to Promote PharmaMar S.A.'s Yondelis(R) Cancer Treatment 12/3/2007 9:17:09 AM
Dr. Enrique Sendagorta Appointed Managing Director Of PharmaMar S.A. 1/22/2007 10:58:27 AM
PharmaMar S.A. Release: Successful Planned Independent Analysis Of Pivotal Phase III Trial Of YONDELISĀ® In Ovarian Cancer 10/6/2006 11:52:18 AM
PharmaMar S.A. Reports New Data On Kahalalide-F And Aplidin(R) At ESMO Congress 9/29/2006 4:12:55 PM